A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods

Linda Brubaker M.D. , Geoff Cundiff M.D. , Paul Fine M.D. , Ingrid Nygaard M.D. , Holly Richter Ph.D., M.D. , Anthony Visco M.D. , Halina Zyczynski M.D. , Morton B Brown Ph.D. , Anne Weber M.D.
{"title":"A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods","authors":"Linda Brubaker M.D. ,&nbsp;Geoff Cundiff M.D. ,&nbsp;Paul Fine M.D. ,&nbsp;Ingrid Nygaard M.D. ,&nbsp;Holly Richter Ph.D., M.D. ,&nbsp;Anthony Visco M.D. ,&nbsp;Halina Zyczynski M.D. ,&nbsp;Morton B Brown Ph.D. ,&nbsp;Anne Weber M.D.","doi":"10.1016/S0197-2456(03)00073-4","DOIUrl":null,"url":null,"abstract":"<div><p>The primary aim of this randomized clinical trial is to evaluate whether a standardized modified Burch colposuspension, when added to planned abdominal sacrocolpopexy for the treatment of pelvic organ prolapse, improves the rate of urinary stress continence in subjects without preoperative symptoms of stress urinary incontinence. Secondary aims include comparison of immediate and short-term complications, overall urinary tract function, and other aspects of pelvic health between subjects with and without a concomitant Burch. The value of preoperative urodynamic testing with prolapse reduction will also be compared between subjects with and without a concomitant Burch. This trial is performed through the Pelvic Floor Disorders Network, which is funded by the National Institutes of Health–National Institute of Child Health and Human Development. Subjects will be enrolled at seven clinical centers across the United States and data will be analyzed by the central data coordinating center. Standardized questionnaires and physical observations and measurements will be obtained. The surgical team is masked to the preoperative urodynamic findings, and the patient and research coordinator are masked to treatment assignment. The primary outcome will be determined at 3 months after surgery. Stress continence is defined as absence of stress incontinence symptoms by questionnaire, a negative standardized stress test, and no treatment for stress incontinence other than the study intervention. Additional follow-up occurs at 6, 12, and 24 months. Accrual began in April 2002 and is projected to take 3 years. As of March 6, 2003, 91 patients have been randomized. This article highlights the scientific aspects of trial design for this pivotal clinical trial. The optimal approach to the urinary tract in women treated surgically for prolapse is not known. This trial is designed to provide pelvic surgeons and their patients with scientific data regarding the utility of urodynamics with and without prolapse reduction and the role of colposuspension with sacrocolpopexy.</p></div>","PeriodicalId":72706,"journal":{"name":"Controlled clinical trials","volume":"24 5","pages":"Pages 629-642"},"PeriodicalIF":0.0000,"publicationDate":"2003-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0197-2456(03)00073-4","citationCount":"105","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Controlled clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0197245603000734","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 105

Abstract

The primary aim of this randomized clinical trial is to evaluate whether a standardized modified Burch colposuspension, when added to planned abdominal sacrocolpopexy for the treatment of pelvic organ prolapse, improves the rate of urinary stress continence in subjects without preoperative symptoms of stress urinary incontinence. Secondary aims include comparison of immediate and short-term complications, overall urinary tract function, and other aspects of pelvic health between subjects with and without a concomitant Burch. The value of preoperative urodynamic testing with prolapse reduction will also be compared between subjects with and without a concomitant Burch. This trial is performed through the Pelvic Floor Disorders Network, which is funded by the National Institutes of Health–National Institute of Child Health and Human Development. Subjects will be enrolled at seven clinical centers across the United States and data will be analyzed by the central data coordinating center. Standardized questionnaires and physical observations and measurements will be obtained. The surgical team is masked to the preoperative urodynamic findings, and the patient and research coordinator are masked to treatment assignment. The primary outcome will be determined at 3 months after surgery. Stress continence is defined as absence of stress incontinence symptoms by questionnaire, a negative standardized stress test, and no treatment for stress incontinence other than the study intervention. Additional follow-up occurs at 6, 12, and 24 months. Accrual began in April 2002 and is projected to take 3 years. As of March 6, 2003, 91 patients have been randomized. This article highlights the scientific aspects of trial design for this pivotal clinical trial. The optimal approach to the urinary tract in women treated surgically for prolapse is not known. This trial is designed to provide pelvic surgeons and their patients with scientific data regarding the utility of urodynamics with and without prolapse reduction and the role of colposuspension with sacrocolpopexy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阴道固定术和尿量减少(CARE)的随机试验:设计和方法
本随机临床试验的主要目的是评估标准改良Burch阴道悬浮液与计划中的腹腔骶阴道固定术一起用于治疗盆腔器官脱垂时,是否能改善术前无压力性尿失禁症状的受试者的尿压力性失禁率。次要目的包括比较有Burch和没有Burch的受试者之间的近期和短期并发症、泌尿道整体功能和盆腔健康的其他方面。术前尿动力学检查与脱垂减少的价值也将在伴有和不伴有Burch的受试者之间进行比较。这项试验是通过盆底疾病网络进行的,该网络由美国国立卫生研究院——国家儿童健康与人类发展研究所资助。受试者将在美国的七个临床中心登记,数据将由中央数据协调中心进行分析。将获得标准化问卷和物理观察和测量结果。手术小组对术前尿动力学结果不知情,患者和研究协调员对治疗任务不知情。主要结果将在术后3个月确定。压力性尿失禁的定义是通过问卷调查、阴性的标准化压力测试没有出现压力性尿失禁症状,并且除了研究干预之外没有对压力性尿失禁进行任何治疗。在6、12和24个月进行额外随访。应计项目于2002年4月开始,预计需要3年。截至2003年3月6日,91名患者被随机分配。本文重点介绍了这项关键临床试验的试验设计的科学方面。女性手术治疗脱垂的最佳方法尚不清楚。该试验旨在为盆腔外科医生及其患者提供有关有无脱垂的尿动力学的应用以及阴道悬吊在骶阴道固定术中的作用的科学数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Editorial Board On the generation and ownership of alpha in medical studies Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels Geographic variability in patient characteristics, treatment and outcome in an international trial of magnesium in acute myocardial infarction Analyzing bronchodilation with emphasis on disease type, age and sex
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1